| Quote | Spy CEPH NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
CEPH Posted by PR Newswire - October 27, 04:10PM FRAZER, Pa., Oct. 27 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today reported third quarter 2009 net sales more ...
The Twenty Companies That Wall St. Can Trust The Least
DOW GE WFC CVX WMT KLAC PNC MO FISV HOLX CEPH BSX CEG NDAQ CS WU BK BX Linked by 24/7 Wall St. - October 27, 05:31AM from (247wallst.com) Wall St. likes financial statements that give it deep insight into a company's operations, especially its liabilities. It more ...
Cephalon downgraded to "neutral"
CEPH Linked by newratings - October 07, 04:13PM from (www.newratings.com) NEW YORK, October 7 (newratings.com) - Analysts at Robert W Baird downgrade Cephalon (ticker: CEPH) from "outperform" more ...
Analyst upgrades, downgrades and initiations: ANN, DIS, CSCO, KO, NWS, PETM, ULTA ...
KO GR RBN STJ BAIRY SNN CSCO PETM CEPH ANN DIS NOV PWR ARO NWY NWS VIA.B ULTA Linked by BloggingStocks - October 07, 11:43AM from (www.pheedcontent.com) Analyst upgrades: Deutsche Bank upgraded Coca-Cola (NYSE: KO) to Buy from Hold on expectations that stable more ...
Earnings highlights: Nike, Walgreen, Jabil Circuit, Gannett, Darden ...
CALM GCI WAG NKE CEPH JBL DRI ACN Linked by BloggingStocks - October 03, 11:43AM from (www.pheedcontent.com) Here are some highlights from last week's earnings coverage from BloggingStocks: Accenture Ltd. (NYSE: more ...
Analyst upgrades, downgrades and initiations: AAPL, BAC, C, CMCSA, NOK, USB ...
AVY BKR USB FRX GE BAC AAPL MRTN C EXM RTP XTO CEPH NOK ETFC ENDP CMCSA FSLR EHTH Linked by BloggingStocks - October 02, 11:43AM from (www.pheedcontent.com) Analyst upgrades: UBS upgraded Apple (NASDAQ: AAPL) to Buy from Neutral and raised its target to $265 from more ...
When Key Biotechs Have Low P/E’s & Value Screens
AMGN GENZ CEPH BIIB PDLI CBST Linked by 24/7 Wall St. - August 24, 09:54AM from (feedproxy.google.com) It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the overall market or even more ...
Cephalon Tops Q2 EPS by 26c; Issues Mixed Guidance for Q3 and FY
CEPH Linked by StreetInsider - August 04, 04:35PM from (www.streetinsider.com) more ...
Human Genome Triples on Successful Lupus Study
GE QLTI CEPH VRTX GERN HGSI UTHR ZGEN GSK MSHL Linked by tickerspy blog - July 20, 11:13AM from (www.tickerspy.com) Shares of Human Genome Sciences (HGSI) shot ahead by over 200% on Monday on a massive volume spike. Announced more ...
A Rising Tide Does Not Lift All Boats
KEY PHM CEPH GME PBCT Linked by Investopedia Stock Analysis - July 07, 12:53PM from (stocks.investopedia.com) The market had its best quarterky return since 1998, but not all stocks participated in this rebound. more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|